SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-24-004393
Filing Date
2024-03-12
Accepted
2024-03-12 13:47:17
Documents
1
Period of Report
2024-03-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-65147.html 4  
1 PRIMARY DOCUMENT marketforms-65147.xml 4 3508
  Complete submission text file 0001214659-24-004393.txt   4994
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
BRAENDER LORI J (Reporting) CIK: 0001752955 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 24741402